Mazar Andrew Paul — insider trades

Stock trades Mazar Andrew Paul reported on SEC Form 4 at MNPR Monopar Therapeutics.

• Sep 24, 2025: sold 550,229 shares of MNPR Monopar Therapeutics ($35.0M)
• Apr 2, 2025: sold 33,334 shares of MNPR Monopar Therapeutics ($1.17M)